Literature DB >> 13513777

Contractility of actomyosin bands prepared from normal and failing human hearts.

K KAKO, R J BING.   

Abstract

Entities:  

Keywords:  MUSCLE PROTEINS/physiology

Mesh：

Substances：

Year:  1958        PMID： 13513777      PMCID： PMC293106          DOI： 10.1172/JCI103626

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  12 in total

1.  Effects of epinephrine and calcium on the electrogram of the ouabainized frog heart.

Authors:  W W BAKER; J M BAKER
Journal:  Circ Res       Date:  1955-05       Impact factor: 17.367

2.  Composition and state of protein in heart muscle of normal dogs and dogs with experimental myocardial failure.

Authors:  E S BENSON
Journal:  Circ Res       Date:  1955-03       Impact factor: 17.367

3.  [The effective mechanism of cardiac glycosides].

Authors:  W WILBRANDT
Journal:  Schweiz Med Wochenschr       Date:  1955-04-02

4.  Changes in muscles after death.

Authors:  E C BATE-SMITH; J R BENDALL
Journal:  Br Med Bull       Date:  1956-09       Impact factor: 4.291

5.  Contractility and extractability of heart actomyosin after death.

Authors:  R J BING; L DETTLI
Journal:  Circ Res       Date:  1956-09       Impact factor: 17.367

6.  Molecular events in cardiac failure.

Authors:  R E OLSON
Journal:  Am J Med       Date:  1956-02       Impact factor: 4.965

7.  The importance of metabolic pathways for the positive inotropic actions of cardiac glycosides and calcium ions.

Authors:  S ELLIS
Journal:  J Pharmacol Exp Ther       Date:  1953-11       Impact factor: 4.030

8.  Effect of ouabain on actomyosin threads.

Authors:  J S ROBB; S MALLOV
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

9.  Some factors influencing the contractility of a non-conducting fiber preparation.

Authors:  S KOREY
Journal:  Biochim Biophys Acta       Date:  1950-01

10.  Binding of calcium and magnesium by the contractile elements.

Authors:  E BOZLER
Journal:  J Gen Physiol       Date:  1955-07-20       Impact factor: 4.086
View more
  9 in total

1.  [EARLY ENZYME HISTOCHEMICAL CHANGES IN EXPERIMENTAL HEART INFARCT].

Authors:  A HECHT
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1964-05-22

2.  [ON A SIDE-EFFECT OF CARDIAC GLYCOSIDES ON THE VISCOSITY OF THE BLOOD].

Authors:  H E MUELLER
Journal:  Blut       Date:  1964-03

3.  HIGH ENERGY PHOSPHATE COMPOUNDS IN THE MYOCARDIUM DURING EXPERIMENTAL CONGESTIVE HEART FAILURE. PURINE AND PYRIMIDINE NUCLEOTIDES, CREATINE, AND CREATINE PHOSPHATE IN NORMAL AND IN FAILING HEARTS.

Authors:  A C FOX; N S WIKLER; G E REED
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

4.  The heart and digitalis.

Authors:  J MCMICHAEL
Journal:  Br Med J       Date:  1963-07-13

5.  STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE.

Authors:  E Braunwald; R D Bloodwell; L I Goldberg; A G Morrow
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

Review 6.  Thick filament proteins and performance in human heart failure.

Authors:  Bradley M Palmer
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

7.  Changes in enzyme activity and electrolite content in the myocardium in experimental myocardial hypertrophy and insufficiency.

Authors:  A M Vihert; N M Pozdyunina
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1969

Review 8.  [The significance of creatine phosphate and adenosine triphosphate in terms of energy production, transport and utilization in the healthy and insufficient heart muscle].

Authors:  S Nägle
Journal:  Klin Wochenschr       Date:  1970-03-15

9.  Thin myofilament proteins in norm and heart failure. I. Polymerizability of myocardial Straub actin in acute and chronic heart failure.

Authors:  N V Karsanov; M P Pirtskhalaishvili; V J Semerikova; N Sh Losaberidze
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.